KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Goodwill: 2020-2025

Historic Goodwill for Supernus Pharmaceuticals (SUPN) over the last 6 years, with Sep 2025 value amounting to $119.1 million.

  • Supernus Pharmaceuticals' Goodwill rose 1.76% to $119.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.1 million, marking a year-over-year increase of 1.76%. This contributed to the annual value of $117.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Supernus Pharmaceuticals' Goodwill is $119.1 million, which was up 1.76% from $117.0 million recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Goodwill peaked at $119.1 million during Q3 2025, and registered a low of $77.9 million during Q1 2021.
  • Its 3-year average for Goodwill is $117.2 million, with a median of $117.0 million in 2025.
  • Within the past 5 years, the most significant YoY rise in Supernus Pharmaceuticals' Goodwill was 50.83% (2021), while the steepest drop was 12.54% (2021).
  • Supernus Pharmaceuticals' Goodwill (Quarterly) stood at $117.5 million in 2021, then dropped by 0.42% to $117.0 million in 2022, then remained steady at $117.0 million in 2023, then remained steady at $117.0 million in 2024, then increased by 1.76% to $119.1 million in 2025.
  • Its Goodwill was $119.1 million in Q3 2025, compared to $117.0 million in Q2 2025 and $117.0 million in Q1 2025.